Arena Pharmaceuticals Inc (NASDAQ:ARNA)

Delayed Data
As of Jan 17
 +0.395 / +0.85%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 66.00, with a high estimate of 79.00 and a low estimate of 51.00. The median estimate represents a +41.42% increase from the last price of 46.67.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.17%
Growthannually 1,388.69%


Growthquarterly 37.09%
Growthannually 4,380.71%
Key to the earnings and sales forecast charts.